OBJECTIVE:To describe the performance and results of CIs (cochlear implant) in patients with AN (auditory neuropathy) and to present a medical literature review.
MATERIALS and METHODS:Retrospective chart review of patients with AN who were treated with CI. The mesh terms used for the review in the Pubmed and Scopus databases were as follows: "hearing loss, cochlear implants, rehabilitation of persons with hearing impairment, auditory neuropathy". Statistical Analyses: The Mann-Whitney test was performed.
RESULTS:The sample consisted of 10 patients. The mean age at surgery was 4.3 years, range 2-16 years. The average length of CI use was 5.2 years. The comparison of hearing levels before and after CI use showed a significant improvement in all patients, with p<0.05. All of them also reported an increase in overall satisfaction 1 year after the procedure. A CI is the standard treatment for the hearing rehabilitation of patients with severe profound hearing loss who do not benefit from conventional hearing aids. There are diseases such as AN that also invoke a discussion in the literature regarding CI benefits.
CONCLUSION:Individuals with an demonstrated a significant gain in hearing levels and language use with CI.
KEYWORDS:Auditory neuropathy spectrum disorder, evoked auditory brainstem response, otoacoustic emissions, GJB2, hearing loss, cochlear implants
Guilherme Machado de Carvalho, Priscila Ramos, Castilho Arthur, Alexandre Guimarães, Edi SartoratoDepartment of Ear Nose Throat Head and Neck Surgery, UNICAMP (Campinas University, São Paulo, Brazil), Campinas, Brazil (GMDC, CA, AG) Centro de Biologia Molecular e Engenharia Genética, UNICAMP (Campinas University, São Paulo, Brazil), Campinas, Brazil (PR, ES) 8 Cochlear implants (CI) currently has ample evidence for its efficacy in the treatment of various forms of deafness, from unilateral to bilateral cases with severe to profound hearing loss. It also has been shown as an alternative for hearing rehabilitation in many conditions, such as in deafness with residual hearing at low frequencies and AN. In AN cases, CI is an option when the patient has not had a good response to conventional hearing aids and an adequate development of speech [1,3,5,10,11] .Although it has been demonstrated that the earlier use of CI in children with AN with severe or profound hearing loss leads to an important benefit in most cases, the situation is still challenging in cases when the hearing loss is moderate [1,3] . Thus, CI has shown conflicting results worldwide, probably because AN must be heterogeneous and have different etiologies [5] .A recent systematic review evaluated the improvement of speech development in children with AN treated with CIs and showed favorable results after CI regarding hearing and speech parameters but concluded that the evidence for CI is still weak and further studies are needed to clarify where and when CI could be applied as a good option for pediatric patients with AN [12] .Regarding the etiologic heterogeneity of AN, it is not surprising that ...